CAPECCHI, PIER LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 13.220
EU - Europa 10.588
AS - Asia 5.584
SA - Sud America 972
AF - Africa 282
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 30.674
Nazione #
US - Stati Uniti d'America 13.046
GB - Regno Unito 2.473
RU - Federazione Russa 2.010
CN - Cina 1.999
SG - Singapore 1.720
IE - Irlanda 1.321
IT - Italia 1.169
BR - Brasile 832
SE - Svezia 799
DE - Germania 736
UA - Ucraina 695
FR - Francia 575
VN - Vietnam 536
HK - Hong Kong 440
FI - Finlandia 431
KR - Corea 264
IN - India 178
ZA - Sudafrica 109
CA - Canada 96
ES - Italia 74
TR - Turchia 71
NL - Olanda 63
BD - Bangladesh 59
MX - Messico 51
AR - Argentina 48
CI - Costa d'Avorio 45
IQ - Iraq 44
NG - Nigeria 44
PL - Polonia 41
BE - Belgio 39
JP - Giappone 39
PK - Pakistan 31
AT - Austria 28
CZ - Repubblica Ceca 28
EC - Ecuador 24
TH - Thailandia 24
VE - Venezuela 21
KE - Kenya 17
MA - Marocco 17
AU - Australia 16
ID - Indonesia 15
IR - Iran 15
EG - Egitto 14
AZ - Azerbaigian 13
CH - Svizzera 13
LT - Lituania 13
PH - Filippine 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
CO - Colombia 12
KZ - Kazakistan 12
SA - Arabia Saudita 12
IL - Israele 11
UZ - Uzbekistan 11
RO - Romania 10
GR - Grecia 9
JO - Giordania 9
ET - Etiopia 8
JM - Giamaica 8
NP - Nepal 8
PE - Perù 8
BO - Bolivia 7
DZ - Algeria 7
EU - Europa 7
OM - Oman 7
PY - Paraguay 7
AL - Albania 6
BG - Bulgaria 6
HR - Croazia 6
LV - Lettonia 6
CL - Cile 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
KG - Kirghizistan 5
MY - Malesia 5
RS - Serbia 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
BY - Bielorussia 3
HN - Honduras 3
LB - Libano 3
LK - Sri Lanka 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
IM - Isola di Man 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 30.647
Città #
Southend 2.190
Dallas 1.591
Fairfield 1.433
Dublin 1.295
Ashburn 1.089
Singapore 961
Chandler 691
Woodbridge 673
Moscow 561
Santa Clara 554
Jacksonville 553
Houston 547
Wilmington 536
Seattle 518
Beijing 496
Cambridge 463
Hong Kong 425
Siena 397
San Jose 373
Ann Arbor 363
Menlo Park 358
Hefei 336
Seoul 259
Helsinki 253
Princeton 242
The Dalles 232
Nanjing 201
Los Angeles 170
New York 164
Ho Chi Minh City 147
Munich 147
Lauterbourg 138
Dong Ket 135
Council Bluffs 115
Dearborn 108
Milan 107
Boardman 106
Hanoi 104
Johannesburg 101
San Diego 93
San Mateo 88
São Paulo 88
Buffalo 87
Florence 78
Nanchang 74
Shanghai 60
Turku 57
Shenyang 54
Columbus 50
Orem 49
Abidjan 45
Brooklyn 45
Bengaluru 43
Düsseldorf 43
Abuja 39
London 39
Málaga 39
San Francisco 39
Toronto 38
Brussels 37
Changsha 37
Chicago 37
Rome 37
Nuremberg 36
Redondo Beach 33
Frankfurt am Main 32
Tianjin 32
Chennai 31
Guangzhou 31
Hebei 31
Tokyo 31
Warsaw 30
Poggiomarino 29
Izmir 27
Kunming 27
Phoenix 27
Jiaxing 25
Lappeenranta 25
Jinan 24
Lancaster 24
Montreal 24
Rio de Janeiro 24
Norwalk 23
Atlanta 22
Da Nang 22
Mumbai 22
Poplar 22
Amsterdam 21
Denver 21
Falls Church 21
Ankara 20
Stockholm 19
Zhengzhou 18
Boston 17
Washington 17
Belo Horizonte 16
Manchester 16
Fremont 15
Baghdad 14
Haiphong 14
Totale 21.311
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 414
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 393
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 393
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 382
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 376
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 361
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 358
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 353
Antirheumatic agents in covid-19: is IL-6 the right target? 352
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 330
Peripheral biomarkers' panel for severe COVID-19 patients 316
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 313
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 312
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 308
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 307
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 307
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 304
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 294
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 294
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 288
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 278
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 277
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 276
Allopurinol prevents ischaemia-dependent haemorheological changes 272
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 268
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 257
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 256
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 255
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 255
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 253
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 250
Torsades de Pointes in patients with polymyalgia rheumatica 246
Serial KL-6 measurements in COVID-19 patients 245
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 241
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 241
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 241
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 240
The role of P2X7 receptors in tissue fibrosis: a brief review 238
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 237
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 237
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 234
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 233
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 232
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 232
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 231
Heart failure and chronic kidney disease in a registry of internal medicine wards 230
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 230
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 228
Statins and the joint: multiple targets for a global protection? 227
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 226
Human rheumatoid synoviocytes express functional P2X7 receptors 225
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 223
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 221
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 219
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 217
Risk factors for hospital readmission of elderly patients 216
Connective tissue diseases and cardiac rhythm disorders: an overview 215
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 212
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 210
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 207
Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment 207
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 202
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 198
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 197
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 197
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 196
Pathogenesis of the novel autoimmune-associated long-QT syndrome 196
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 195
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 194
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 192
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 188
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 186
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 185
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 185
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 184
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 184
Familial Mediterranean fever diagnosed in an elderly patient 182
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 181
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 180
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 180
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 179
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 175
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 175
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 175
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 174
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 174
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 173
Photopheresis immunomodulation after heart transplantation. 173
ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family 172
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 171
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 170
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 170
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 169
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 168
Enhanced apoptosis of peripheral blood mononuclear cells (PBMC) in cardiac transplanted patients undergoing chronic immunosuppressive treatment 168
Homocysteine and Raynaud’s phenomenon: a review 167
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b 166
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 166
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 163
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 163
Totale 23.506
Categoria #
all - tutte 94.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021811 0 0 0 0 0 0 0 0 0 284 254 273
2021/20222.192 159 283 133 169 159 74 130 96 138 195 220 436
2022/20232.560 161 250 366 373 204 501 74 187 265 55 68 56
2023/20242.219 93 48 176 111 110 613 686 54 26 62 61 179
2024/20254.344 85 216 392 266 520 257 183 264 315 217 500 1.129
2025/20269.236 866 1.494 1.051 1.139 1.923 461 1.233 256 358 455 0 0
Totale 31.064